Cigna vs McKesson
CI and MCK side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CI and MCK compare
McKesson is the larger company, worth 1.6 times as much as Cigna ($126B against $79.7B).
On earnings, Cigna is cheaper: it trades at 13.3× trailing earnings, against 27.8× for McKesson.
McKesson grew revenue faster over the last twelve months (8.2% versus 6.8% for Cigna).
Cigna keeps more of each dollar of sales as profit, with a net margin of 2.1% compared with 1.1% at McKesson.
Both pay dividends: Cigna yields 2.1% and McKesson 0.31%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CI | MCK |
|---|---|---|
| Size and price | ||
| Market cap | $79.7B | $126B |
| Share price | $301.45 | $1079.79 |
| Change, 1 year | 16.8% | 25.6% |
| Change, 5 years | 43.2% | 389% |
| Beta (5Y) | 0.34 | 0.30 |
| Employees | 68K | 43K |
| StockData Score | ||
| Total score | 16 | 16 |
| Valuation score | 6 (better) | 1 |
| Growth score | 2 | 5 (better) |
| Performance score | 3 | 3 |
| Health score | 2 | 3 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 13.3× (better) | 27.8× |
| P/S | 0.3× (better) | 0.3× |
| P/B | 1.8× | – |
| EV/EBITDA | 8.2× (better) | 18.4× |
| P/FCF | – | 17.7× |
| PEG | 11.23 | 1.81 (better) |
| FCF yield | – | 5.6% |
| Fair value | $383.88 | $881.37 |
| Margin of safety | 21.5% (better) | −22.5% |
| Growth | ||
| Revenue growth (TTM) | 6.8% | 8.2% (better) |
| Revenue growth, 5Y average | 11.4% (better) | 11.1% |
| Net income growth (TTM) | – | 16.5% |
| EPS growth (TTM) | −0.04% | 21.0% (better) |
| EPS growth, 5Y average | −0.69% | – |
| Profitability | ||
| Gross margin | 20.7% (better) | 3.7% |
| Operating margin | 3.4% (better) | 1.6% |
| Net margin | 2.1% (better) | 1.1% |
| FCF margin | – | 1.7% |
| Return on equity | 14.1% | – |
| Return on invested capital | 11.4% | 1481% (better) |
| Financial health | ||
| Debt / equity | 0.72 | – |
| Net debt / EBITDA | 1.88 | 0.38 (better) |
| Interest coverage | 7.1× | 21.9× (better) |
| Current ratio | 0.84 | 0.90 (better) |
| Altman Z-score | 2.83 | 5.83 (better) |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.1% (better) | 0.31% |
| Payout ratio | 27.2% | 8.5% |
| Years of dividend growth | 5 | 13 (better) |
| Dividend growth, 5Y average | 173% (better) | 13.7% |
| Buyback yield | 1.7% | 5.4% (better) |
| Shareholder yield | 3.7% | 5.7% (better) |
| Ownership | ||
| Held by institutions | 89.9% | 90.4% |
| Held by insiders | 0.41% | 0.05% |
| Insider net buying, 12 months | −$66.8M | −$30.1M (better) |
| Superinvestors holding | 4 (better) | 1 |
| Short interest, % of float | 2.4% | 1.7% |
Go deeper
- CI stock overview
- CI income statement
- CI valuation and score
- MCK stock overview
- MCK income statement
- MCK valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.